Gene Symbol | Gene ID | Gene Info |
---|---|---|
En2
|
ENSMUSG00000039095.7 | engrailed 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_28165381_28165955 | En2 | 26 | 0.974532 | 0.74 | 1.6e-10 | Click! |
chr5_28158467_28158630 | En2 | 7146 | 0.187049 | 0.73 | 1.8e-10 | Click! |
chr5_28165997_28166156 | En2 | 382 | 0.840959 | 0.69 | 6.7e-09 | Click! |
chr5_28123165_28123337 | En2 | 42443 | 0.112147 | 0.59 | 2.6e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_69303567_69303898 | 15.47 |
Gm36487 |
predicted gene, 36487 |
12262 |
0.17 |
chr2_63963076_63963322 | 14.54 |
Fign |
fidgetin |
134789 |
0.06 |
chr11_112501711_112502406 | 13.63 |
BC006965 |
cDNA sequence BC006965 |
167340 |
0.04 |
chr12_44839950_44840386 | 13.61 |
Gm15901 |
predicted gene 15901 |
83012 |
0.1 |
chr10_73821665_73822034 | 12.91 |
Pcdh15 |
protocadherin 15 |
18 |
0.99 |
chr2_50971381_50971555 | 12.75 |
Gm13498 |
predicted gene 13498 |
61784 |
0.14 |
chr12_56004549_56004776 | 12.72 |
Gm5183 |
predicted gene 5183 |
45871 |
0.13 |
chr4_21689447_21689958 | 12.24 |
Prdm13 |
PR domain containing 13 |
3739 |
0.21 |
chr6_12337029_12337231 | 12.12 |
Thsd7a |
thrombospondin, type I, domain containing 7A |
12437 |
0.3 |
chr10_8348667_8348983 | 11.88 |
Ust |
uronyl-2-sulfotransferase |
46583 |
0.19 |
chr13_52457883_52458068 | 11.80 |
Diras2 |
DIRAS family, GTP-binding RAS-like 2 |
73304 |
0.12 |
chr8_69160881_69161314 | 11.77 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
20144 |
0.15 |
chr17_49044163_49044341 | 11.64 |
Gm44304 |
predicted gene, 44304 |
52181 |
0.14 |
chr3_35090595_35090820 | 11.58 |
Mir6378 |
microRNA 6378 |
168056 |
0.03 |
chr8_26265045_26265237 | 11.44 |
Gm31727 |
predicted gene, 31727 |
1836 |
0.25 |
chr11_43548063_43548966 | 11.35 |
Ccnjl |
cyclin J-like |
19268 |
0.13 |
chr13_63985759_63985962 | 11.21 |
Gm7695 |
predicted gene 7695 |
39339 |
0.14 |
chr13_101203160_101203326 | 11.13 |
5930438M14Rik |
RIKEN cDNA 5930438M14 gene |
28884 |
0.19 |
chr8_12126295_12126640 | 10.93 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
152352 |
0.03 |
chr13_99444397_99444879 | 10.72 |
Map1b |
microtubule-associated protein 1B |
171 |
0.95 |
chr11_39596506_39596789 | 10.71 |
Gm12131 |
predicted gene 12131 |
131065 |
0.06 |
chr5_37768904_37769238 | 10.69 |
Cytl1 |
cytokine-like 1 |
31791 |
0.15 |
chr2_54265163_54265368 | 10.57 |
Gm14035 |
predicted gene 14035 |
18850 |
0.21 |
chr17_17402608_17403030 | 10.44 |
Lix1 |
limb and CNS expressed 1 |
147 |
0.94 |
chr1_42695585_42695788 | 10.37 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
82 |
0.89 |
chr15_44705846_44706012 | 10.36 |
Sybu |
syntabulin (syntaxin-interacting) |
41859 |
0.15 |
chr10_87489779_87490093 | 10.27 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
3724 |
0.24 |
chr6_40024235_40024578 | 10.26 |
Gm37995 |
predicted gene, 37995 |
2488 |
0.33 |
chr12_51002047_51002408 | 10.18 |
Gm40421 |
predicted gene, 40421 |
2646 |
0.28 |
chr11_21713646_21713804 | 10.03 |
Wdpcp |
WD repeat containing planar cell polarity effector |
18596 |
0.2 |
chr8_13454338_13454755 | 9.97 |
Tmem255b |
transmembrane protein 255B |
932 |
0.51 |
chr10_51153683_51154077 | 9.97 |
Gm26257 |
predicted gene, 26257 |
28419 |
0.22 |
chr5_116895407_116895611 | 9.81 |
Gm43122 |
predicted gene 43122 |
64955 |
0.1 |
chr4_48779650_48779836 | 9.81 |
Gm24573 |
predicted gene, 24573 |
16781 |
0.2 |
chr2_146710690_146711112 | 9.79 |
Gm14111 |
predicted gene 14111 |
44804 |
0.18 |
chr2_6594788_6595061 | 9.69 |
Celf2 |
CUGBP, Elav-like family member 2 |
2124 |
0.42 |
chr12_13845175_13845385 | 9.55 |
Gm49374 |
predicted gene, 49374 |
52943 |
0.11 |
chr3_98990771_98991097 | 9.45 |
5730437C11Rik |
RIKEN cDNA 5730437C11 gene |
49678 |
0.1 |
chr3_34504632_34504783 | 9.42 |
Gm29135 |
predicted gene 29135 |
22500 |
0.16 |
chr3_141943522_141943718 | 9.38 |
Bmpr1b |
bone morphogenetic protein receptor, type 1B |
12097 |
0.29 |
chr5_103335878_103336033 | 9.28 |
Gm42619 |
predicted gene 42619 |
8017 |
0.16 |
chr10_87500912_87501095 | 9.23 |
Gm48120 |
predicted gene, 48120 |
6859 |
0.19 |
chr13_29349395_29349902 | 9.17 |
Gm11364 |
predicted gene 11364 |
113028 |
0.07 |
chr18_17383276_17383802 | 9.16 |
4921533I20Rik |
Riken cDNA 4921533I20 gene |
63809 |
0.15 |
chr18_42739913_42740099 | 9.14 |
C030004G16Rik |
RIKEN cDNA C030004G16 gene |
117547 |
0.05 |
chr6_126645496_126645701 | 9.14 |
Kcna1 |
potassium voltage-gated channel, shaker-related subfamily, member 1 |
785 |
0.67 |
chr11_43747463_43748363 | 9.13 |
Ttc1 |
tetratricopeptide repeat domain 1 |
69 |
0.98 |
chr2_46297559_46297710 | 9.11 |
Gm23072 |
predicted gene, 23072 |
8702 |
0.3 |
chr14_35112923_35113111 | 9.09 |
Gm49034 |
predicted gene, 49034 |
106421 |
0.07 |
chr17_84749518_84749672 | 9.08 |
Lrpprc |
leucine-rich PPR-motif containing |
1667 |
0.35 |
chr5_62581784_62581962 | 9.08 |
Arap2 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
30501 |
0.17 |
chr9_65267989_65268185 | 9.06 |
Cilp |
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase |
2264 |
0.19 |
chr9_5752747_5752938 | 9.00 |
Gm48506 |
predicted gene, 48506 |
43937 |
0.19 |
chr8_118004421_118004600 | 8.92 |
Gm25200 |
predicted gene, 25200 |
116444 |
0.06 |
chr6_77075373_77076013 | 8.88 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
68250 |
0.13 |
chr12_29279690_29280795 | 8.86 |
Gm6989 |
predicted gene 6989 |
37326 |
0.21 |
chr15_59040434_59041094 | 8.83 |
Mtss1 |
MTSS I-BAR domain containing 1 |
167 |
0.96 |
chr17_69686012_69686193 | 8.83 |
Gm49895 |
predicted gene, 49895 |
89910 |
0.08 |
chr18_21185734_21186067 | 8.80 |
Gm6378 |
predicted pseudogene 6378 |
108791 |
0.05 |
chr8_23360756_23361303 | 8.79 |
Sfrp1 |
secreted frizzled-related protein 1 |
50473 |
0.12 |
chr4_141011762_141012413 | 8.78 |
Mfap2 |
microfibrillar-associated protein 2 |
1443 |
0.27 |
chr3_66102086_66102567 | 8.66 |
Gm36973 |
predicted gene, 36973 |
2521 |
0.19 |
chr9_23378360_23378672 | 8.55 |
Bmper |
BMP-binding endothelial regulator |
4584 |
0.36 |
chr13_82620860_82621103 | 8.51 |
Mir3961 |
microRNA 3961 |
77352 |
0.12 |
chr9_37028261_37028476 | 8.48 |
n-R5s82 |
nuclear encoded rRNA 5S 82 |
1969 |
0.29 |
chr6_144251546_144251744 | 8.46 |
Sox5 |
SRY (sex determining region Y)-box 5 |
42077 |
0.21 |
chr2_146724098_146724249 | 8.45 |
Gm14111 |
predicted gene 14111 |
31532 |
0.22 |
chr10_100111276_100111504 | 8.38 |
Kitl |
kit ligand |
23334 |
0.13 |
chr8_93917610_93917784 | 8.36 |
Gm24159 |
predicted gene, 24159 |
16239 |
0.16 |
chr5_107497898_107498054 | 8.36 |
Btbd8 |
BTB (POZ) domain containing 8 |
197 |
0.9 |
chr11_44785172_44785367 | 8.34 |
Gm12158 |
predicted gene 12158 |
122593 |
0.05 |
chr12_45929501_45929668 | 8.34 |
Gm24948 |
predicted gene, 24948 |
54759 |
0.17 |
chr10_19396813_19397100 | 8.33 |
Olig3 |
oligodendrocyte transcription factor 3 |
40423 |
0.16 |
chr3_94465598_94465829 | 8.31 |
Riiad1 |
regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1 |
7209 |
0.08 |
chr8_26255231_26255419 | 8.26 |
Gm31727 |
predicted gene, 31727 |
11652 |
0.12 |
chr4_96969208_96969597 | 8.22 |
Gm27521 |
predicted gene, 27521 |
52382 |
0.15 |
chr17_11927079_11927230 | 8.19 |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
81944 |
0.1 |
chr17_90892371_90892658 | 8.16 |
4930480K15Rik |
RIKEN cDNA 4930480K15 gene |
31345 |
0.22 |
chr10_101373884_101374182 | 8.15 |
Gm19233 |
predicted gene, 19233 |
102412 |
0.08 |
chr2_97543948_97544112 | 8.15 |
Lrrc4c |
leucine rich repeat containing 4C |
75941 |
0.11 |
chr15_52384572_52384762 | 8.07 |
Gm41322 |
predicted gene, 41322 |
60455 |
0.12 |
chr4_125545547_125545968 | 8.02 |
Mir692-2 |
microRNA 692-2 |
41008 |
0.15 |
chr16_59854456_59854822 | 8.01 |
Epha6 |
Eph receptor A6 |
151082 |
0.04 |
chr13_115911152_115911322 | 7.97 |
Gm18135 |
predicted gene, 18135 |
140301 |
0.05 |
chr12_86911691_86911906 | 7.90 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
27000 |
0.14 |
chr5_54411627_54411808 | 7.90 |
Gm10440 |
predicted gene 10440 |
61726 |
0.15 |
chr19_47493646_47493894 | 7.87 |
Stn1 |
STN1, CST complex subunit |
15003 |
0.15 |
chr4_109977408_109977780 | 7.85 |
Dmrta2os |
doublesex and mab-3 related transcription factor like family A2, opposite strand |
103 |
0.86 |
chr3_34646262_34646441 | 7.85 |
Gm42692 |
predicted gene 42692 |
3087 |
0.14 |
chr3_80802510_80803270 | 7.83 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
55 |
0.98 |
chr1_68046813_68046988 | 7.76 |
Gm15671 |
predicted gene 15671 |
22657 |
0.22 |
chr5_78622542_78622942 | 7.76 |
Gm43232 |
predicted gene 43232 |
82214 |
0.11 |
chrX_169838405_169838582 | 7.73 |
Mid1 |
midline 1 |
10334 |
0.25 |
chr2_6884852_6885717 | 7.58 |
Celf2 |
CUGBP, Elav-like family member 2 |
288 |
0.83 |
chr15_57590018_57590245 | 7.57 |
Gm49235 |
predicted gene, 49235 |
101260 |
0.06 |
chr3_159851998_159852454 | 7.53 |
Wls |
wntless WNT ligand secretion mediator |
3775 |
0.28 |
chr16_63500963_63501194 | 7.52 |
Gm49622 |
predicted gene, 49622 |
8961 |
0.32 |
chr4_39344820_39345025 | 7.51 |
Gm23607 |
predicted gene, 23607 |
49459 |
0.14 |
chr13_52562127_52562509 | 7.49 |
Syk |
spleen tyrosine kinase |
20855 |
0.22 |
chr7_78887666_78887880 | 7.49 |
Mir7-2 |
microRNA 7-2 |
504 |
0.68 |
chr15_64920763_64921549 | 7.47 |
Adcy8 |
adenylate cyclase 8 |
1115 |
0.61 |
chr1_41814005_41814309 | 7.45 |
Gm29260 |
predicted gene 29260 |
32349 |
0.25 |
chr9_87883201_87883375 | 7.44 |
Gm25528 |
predicted gene, 25528 |
5299 |
0.28 |
chr13_81628689_81629170 | 7.44 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
4210 |
0.23 |
chr15_95640522_95640729 | 7.42 |
Dbx2 |
developing brain homeobox 2 |
7797 |
0.2 |
chr1_4970686_4970886 | 7.39 |
Gm16041 |
predicted gene 16041 |
71 |
0.97 |
chr12_68217227_68217378 | 7.39 |
Gm47454 |
predicted gene, 47454 |
115320 |
0.06 |
chr19_21781727_21782179 | 7.36 |
Cemip2 |
cell migration inducing hyaluronidase 2 |
3565 |
0.26 |
chr1_41749293_41749469 | 7.36 |
Gm29260 |
predicted gene 29260 |
32427 |
0.25 |
chr1_89739411_89739593 | 7.36 |
Agap1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
49661 |
0.13 |
chr4_128492137_128492443 | 7.35 |
Csmd2 |
CUB and Sushi multiple domains 2 |
15136 |
0.24 |
chr2_116042575_116042745 | 7.34 |
Meis2 |
Meis homeobox 2 |
614 |
0.73 |
chr14_80170834_80170985 | 7.32 |
Gm17923 |
predicted gene, 17923 |
44021 |
0.18 |
chr3_80607920_80608085 | 7.31 |
Gm25749 |
predicted gene, 25749 |
84311 |
0.1 |
chr18_50397132_50397306 | 7.30 |
Fam170a |
family with sequence similarity 170, member A |
118848 |
0.06 |
chr17_8368820_8369004 | 7.27 |
T2 |
brachyury 2 |
3484 |
0.15 |
chr13_28774697_28775021 | 7.26 |
Gm17528 |
predicted gene, 17528 |
52264 |
0.13 |
chr12_17557739_17558001 | 7.22 |
Gm36862 |
predicted gene, 36862 |
171 |
0.93 |
chr9_34712119_34712402 | 7.21 |
Gm38217 |
predicted gene, 38217 |
190505 |
0.03 |
chr12_4523765_4524306 | 7.18 |
Gm31938 |
predicted gene, 31938 |
78 |
0.96 |
chr13_84751597_84751791 | 7.15 |
Gm26913 |
predicted gene, 26913 |
60753 |
0.15 |
chr1_139346382_139347077 | 7.11 |
Crb1 |
crumbs family member 1, photoreceptor morphogenesis associated |
18461 |
0.17 |
chr8_34325666_34325912 | 7.11 |
Gm4889 |
predicted gene 4889 |
2121 |
0.21 |
chr4_136786609_136786819 | 7.09 |
Ephb2 |
Eph receptor B2 |
49129 |
0.12 |
chr4_41727338_41727565 | 7.09 |
Arid3c |
AT rich interactive domain 3C (BRIGHT-like) |
2835 |
0.12 |
chr17_68560365_68560556 | 7.09 |
Gm17921 |
predicted gene, 17921 |
138451 |
0.05 |
chr3_134605538_134605802 | 7.08 |
Gm26820 |
predicted gene, 26820 |
25095 |
0.24 |
chr9_45626192_45626360 | 7.08 |
Gm22069 |
predicted gene, 22069 |
8536 |
0.21 |
chr18_47703851_47704052 | 7.06 |
Gm5236 |
predicted gene 5236 |
25816 |
0.18 |
chr15_47991044_47991322 | 7.04 |
Csmd3 |
CUB and Sushi multiple domains 3 |
10438 |
0.32 |
chrX_59241259_59241443 | 7.04 |
Gm14890 |
predicted gene 14890 |
44388 |
0.15 |
chr13_78581171_78581365 | 7.02 |
Gm48402 |
predicted gene, 48402 |
56749 |
0.14 |
chr14_100375280_100375638 | 7.02 |
Gm26367 |
predicted gene, 26367 |
43024 |
0.15 |
chr5_88583308_88583633 | 7.02 |
Rufy3 |
RUN and FYVE domain containing 3 |
43 |
0.97 |
chr6_15397521_15397861 | 7.02 |
Gm25470 |
predicted gene, 25470 |
7290 |
0.26 |
chr1_75725382_75725667 | 7.01 |
Gm5257 |
predicted gene 5257 |
89134 |
0.07 |
chr2_150735739_150736543 | 6.98 |
Gm28450 |
predicted gene 28450 |
11520 |
0.12 |
chr2_21282645_21282991 | 6.97 |
Gm13378 |
predicted gene 13378 |
38713 |
0.15 |
chr12_25871193_25871842 | 6.97 |
Gm47733 |
predicted gene, 47733 |
364 |
0.91 |
chr7_79511969_79512162 | 6.96 |
2900037B21Rik |
RIKEN cDNA 2900037B21 gene |
859 |
0.35 |
chr8_90576969_90577137 | 6.94 |
Gm45639 |
predicted gene 45639 |
97905 |
0.07 |
chr8_61309392_61309892 | 6.94 |
1700001D01Rik |
RIKEN cDNA 1700001D01 gene |
20770 |
0.18 |
chr3_57919632_57919807 | 6.93 |
Gm24531 |
predicted gene, 24531 |
2468 |
0.24 |
chr2_93227691_93228447 | 6.92 |
Tspan18 |
tetraspanin 18 |
283 |
0.93 |
chrX_61823685_61823865 | 6.92 |
Gm6743 |
predicted pseudogene 6743 |
6735 |
0.25 |
chr10_49256416_49256586 | 6.91 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
13465 |
0.18 |
chr18_57263021_57263225 | 6.90 |
Gm50200 |
predicted gene, 50200 |
52017 |
0.11 |
chr9_119888845_119889024 | 6.89 |
Gm2449 |
predicted gene 2449 |
5911 |
0.15 |
chr7_29071400_29071669 | 6.86 |
Gm26604 |
predicted gene, 26604 |
69 |
0.87 |
chr19_21781154_21781434 | 6.84 |
Cemip2 |
cell migration inducing hyaluronidase 2 |
2906 |
0.29 |
chr18_80040460_80040856 | 6.83 |
Pard6g |
par-6 family cell polarity regulator gamma |
6232 |
0.08 |
chr15_4378780_4379184 | 6.83 |
Plcxd3 |
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
3478 |
0.36 |
chr1_82324497_82324671 | 6.81 |
Rhbdd1 |
rhomboid domain containing 1 |
7942 |
0.18 |
chr13_64527016_64527226 | 6.80 |
Gm47190 |
predicted gene, 47190 |
11267 |
0.13 |
chr4_122998402_122999232 | 6.80 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
63 |
0.96 |
chrX_58445733_58445903 | 6.79 |
Gm14645 |
predicted gene 14645 |
17743 |
0.26 |
chr8_25392912_25393353 | 6.75 |
Gm39147 |
predicted gene, 39147 |
5888 |
0.16 |
chr3_110010549_110010756 | 6.75 |
Gm12535 |
predicted gene 12535 |
103268 |
0.07 |
chr5_116208794_116209040 | 6.74 |
Gm14507 |
predicted gene 14507 |
34789 |
0.12 |
chr10_67559869_67560062 | 6.73 |
4930563J15Rik |
RIKEN cDNA 4930563J15 gene |
10073 |
0.12 |
chr3_69709128_69709981 | 6.70 |
Rpl32-ps |
ribosomal protein L32, pseudogene |
7839 |
0.17 |
chr13_107407430_107407612 | 6.70 |
Apoo-ps |
apolipoprotein O, pseudogene |
7208 |
0.24 |
chr19_15801412_15801721 | 6.69 |
Gm50348 |
predicted gene, 50348 |
1492 |
0.52 |
chr7_132184258_132184454 | 6.68 |
Cpxm2 |
carboxypeptidase X 2 (M14 family) |
29617 |
0.16 |
chr9_11279890_11280105 | 6.67 |
Gm18934 |
predicted gene, 18934 |
1954 |
0.42 |
chrX_58689115_58689266 | 6.64 |
Gm7071 |
predicted gene 7071 |
20466 |
0.21 |
chr7_49699721_49700100 | 6.62 |
Htatip2 |
HIV-1 Tat interactive protein 2 |
59205 |
0.11 |
chr19_15340555_15340742 | 6.61 |
Gm24319 |
predicted gene, 24319 |
339356 |
0.01 |
chr1_6752243_6752413 | 6.60 |
St18 |
suppression of tumorigenicity 18 |
14753 |
0.25 |
chr3_76654290_76654629 | 6.60 |
Fstl5 |
follistatin-like 5 |
60909 |
0.15 |
chr2_22294291_22294480 | 6.60 |
Myo3a |
myosin IIIA |
53328 |
0.16 |
chr14_76260875_76261070 | 6.59 |
2900040C04Rik |
RIKEN cDNA 2900040C04 gene |
9515 |
0.23 |
chr1_118776552_118777195 | 6.59 |
Gm28467 |
predicted gene 28467 |
33263 |
0.18 |
chr8_69149162_69149554 | 6.57 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
8405 |
0.17 |
chr18_14844486_14844862 | 6.57 |
Gm21055 |
predicted gene, 21055 |
14006 |
0.21 |
chr13_18127101_18127252 | 6.57 |
4930448F12Rik |
RIKEN cDNA 4930448F12 gene |
26974 |
0.14 |
chr1_52079807_52079978 | 6.57 |
Gm28177 |
predicted gene 28177 |
2631 |
0.2 |
chr2_122351287_122351549 | 6.56 |
Shf |
Src homology 2 domain containing F |
2713 |
0.18 |
chr10_27103841_27103992 | 6.56 |
Lama2 |
laminin, alpha 2 |
47271 |
0.17 |
chr13_43950234_43950637 | 6.55 |
Gm2233 |
predicted gene 2233 |
1556 |
0.43 |
chr3_158559650_158560260 | 6.55 |
Lrrc7 |
leucine rich repeat containing 7 |
1381 |
0.57 |
chr16_42340863_42341164 | 6.55 |
Gap43 |
growth associated protein 43 |
362 |
0.91 |
chr11_35913497_35913742 | 6.53 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
37907 |
0.16 |
chr8_92167277_92167548 | 6.52 |
Gm45335 |
predicted gene 45335 |
5175 |
0.21 |
chr9_41593811_41594013 | 6.51 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
5418 |
0.12 |
chr6_99669465_99669765 | 6.49 |
Gm20696 |
predicted gene 20696 |
2818 |
0.18 |
chr17_88275094_88275304 | 6.48 |
1700116H05Rik |
RIKEN cDNA 1700116H05 gene |
30179 |
0.17 |
chr13_71165452_71165631 | 6.46 |
Mir466f-4 |
microRNA 466f-4 |
58452 |
0.15 |
chr1_25893085_25893254 | 6.45 |
Gm9884 |
predicted gene 9884 |
62512 |
0.08 |
chr13_54884713_54885019 | 6.43 |
Gm29431 |
predicted gene 29431 |
2604 |
0.21 |
chr9_61872624_61872918 | 6.43 |
Gm19208 |
predicted gene, 19208 |
21067 |
0.18 |
chr14_101055920_101056254 | 6.43 |
Prr30 |
proline rich 30 |
143982 |
0.04 |
chrX_38313231_38313611 | 6.42 |
Atp1b4 |
ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
2763 |
0.23 |
chr14_104537843_104538037 | 6.41 |
Rnf219 |
ring finger protein 219 |
15295 |
0.18 |
chr8_26677560_26678005 | 6.40 |
Gm32098 |
predicted gene, 32098 |
9476 |
0.18 |
chr13_95995367_95995681 | 6.39 |
Sv2c |
synaptic vesicle glycoprotein 2c |
5298 |
0.24 |
chr6_23281324_23281501 | 6.39 |
C130093G08Rik |
RIKEN cDNA C130093G08 gene |
30279 |
0.15 |
chr18_74907209_74907702 | 6.38 |
Gm24559 |
predicted gene, 24559 |
1021 |
0.37 |
chr11_11113745_11113896 | 6.35 |
Vwc2 |
von Willebrand factor C domain containing 2 |
403 |
0.89 |
chr1_85916730_85916901 | 6.33 |
Itm2c |
integral membrane protein 2C |
10654 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.8 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
3.7 | 11.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.5 | 13.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
3.5 | 10.4 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
2.7 | 10.8 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
2.7 | 8.1 | GO:0060166 | olfactory pit development(GO:0060166) |
2.6 | 10.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
2.5 | 22.7 | GO:0050957 | equilibrioception(GO:0050957) |
2.2 | 6.5 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.9 | 13.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.8 | 1.8 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.6 | 4.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.6 | 12.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.6 | 6.2 | GO:0060594 | mammary gland specification(GO:0060594) |
1.5 | 7.6 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.3 | 5.2 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.2 | 2.5 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.2 | 4.7 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.1 | 4.5 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.1 | 4.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.1 | 5.4 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.1 | 5.4 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.0 | 3.1 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.0 | 7.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
1.0 | 2.0 | GO:0031223 | auditory behavior(GO:0031223) |
1.0 | 2.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.0 | 4.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.9 | 1.9 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.9 | 4.6 | GO:0036233 | glycine import(GO:0036233) |
0.9 | 3.7 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.9 | 1.8 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.9 | 2.7 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.9 | 2.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.9 | 2.6 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.9 | 7.8 | GO:0071625 | vocalization behavior(GO:0071625) |
0.9 | 1.7 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.9 | 6.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.8 | 3.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.8 | 2.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.8 | 3.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.8 | 2.4 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.8 | 3.1 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.8 | 8.6 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.8 | 2.3 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.8 | 2.3 | GO:0007412 | axon target recognition(GO:0007412) |
0.8 | 2.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.8 | 2.3 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.8 | 1.5 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.7 | 4.4 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.7 | 2.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.7 | 2.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.7 | 2.9 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.7 | 2.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.7 | 2.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.7 | 5.7 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 | 2.1 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.7 | 2.8 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.7 | 2.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.7 | 2.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.7 | 1.4 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.7 | 2.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.7 | 1.4 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.6 | 3.9 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.6 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 1.9 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.6 | 1.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.6 | 1.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.6 | 1.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.6 | 2.4 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.6 | 0.6 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 1.8 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.6 | 1.2 | GO:0070668 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.6 | 4.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.6 | 7.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.6 | 1.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.6 | 7.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 0.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.6 | 1.7 | GO:0046959 | habituation(GO:0046959) |
0.6 | 2.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.6 | 3.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.6 | 1.1 | GO:0061055 | myotome development(GO:0061055) |
0.6 | 3.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.5 | 3.3 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.5 | 2.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.5 | 1.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.5 | 4.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.5 | 1.6 | GO:0001927 | exocyst assembly(GO:0001927) |
0.5 | 3.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.5 | 2.1 | GO:0090427 | activation of meiosis(GO:0090427) |
0.5 | 1.0 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.5 | 1.0 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.5 | 1.5 | GO:0030242 | pexophagy(GO:0030242) |
0.5 | 3.0 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.5 | 1.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.5 | 2.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.5 | 1.0 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.5 | 2.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.5 | 1.5 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.5 | 3.4 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.5 | 1.5 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.5 | 0.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.5 | 1.5 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.5 | 3.4 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.5 | 1.0 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.5 | 1.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.5 | 0.9 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.5 | 1.9 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.5 | 2.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.5 | 1.9 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.5 | 1.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.5 | 2.3 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.5 | 1.4 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.4 | 1.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.4 | 1.8 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.4 | 1.3 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.4 | 2.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 1.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.4 | 3.0 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.4 | 2.2 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.4 | 0.9 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.4 | 2.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.4 | 6.4 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.4 | 2.5 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.4 | 1.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 0.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.4 | 0.8 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.4 | 0.8 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.4 | 0.4 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.4 | 0.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.4 | 1.2 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.4 | 1.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 1.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 2.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.4 | 1.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 6.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.4 | 1.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.4 | 2.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.4 | 0.8 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 0.8 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.4 | 0.8 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.4 | 1.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 1.9 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.4 | 0.8 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.4 | 8.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.4 | 0.4 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.4 | 2.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.4 | 3.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.4 | 1.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.4 | 1.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.4 | 1.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.4 | 2.6 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.4 | 1.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 0.7 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.4 | 1.5 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.4 | 0.7 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.4 | 1.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.4 | 5.1 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.4 | 1.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.4 | 0.7 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.4 | 0.7 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.4 | 2.5 | GO:0071435 | potassium ion export(GO:0071435) |
0.4 | 2.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.4 | 0.4 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.4 | 0.7 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 2.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 2.8 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.3 | 0.3 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 5.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 1.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 1.4 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.3 | 1.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.3 | 2.7 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.3 | 1.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.3 | 2.6 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 0.3 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.3 | 1.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.3 | 1.3 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.3 | 0.6 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.3 | 0.3 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.3 | 0.9 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.3 | 0.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 1.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.3 | 0.9 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.3 | 0.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 0.9 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 5.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.3 | 1.4 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 3.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.3 | 0.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.3 | 0.6 | GO:0033058 | directional locomotion(GO:0033058) |
0.3 | 1.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 0.8 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.3 | 0.8 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.3 | 1.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.5 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.3 | 0.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 1.6 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.3 | 0.3 | GO:0052330 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.3 | 1.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.3 | 0.5 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 0.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.3 | 0.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.3 | 0.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 3.4 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.3 | 1.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 0.5 | GO:0003032 | detection of oxygen(GO:0003032) |
0.3 | 4.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 0.8 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 0.8 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 0.5 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.3 | 0.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 1.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 0.5 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.2 | 2.0 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 0.5 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.2 | 0.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 0.5 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.2 | 0.7 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 1.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.7 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 3.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 1.9 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 1.4 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 1.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 1.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 1.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.2 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 0.7 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 1.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.7 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.2 | 18.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 1.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 5.0 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 0.6 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 1.1 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.2 | 0.6 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 1.3 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 0.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 0.8 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.2 | 0.6 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.2 | 0.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 1.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 2.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 0.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 0.6 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 0.6 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.6 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.6 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.2 | 3.5 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 0.8 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 0.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 0.6 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 1.0 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.2 | 0.8 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 0.9 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.2 | 0.6 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 1.1 | GO:0001964 | startle response(GO:0001964) |
0.2 | 0.9 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.2 | 1.7 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.2 | 0.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 1.8 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.2 | 0.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.4 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.2 | 0.4 | GO:0097576 | vacuole fusion(GO:0097576) |
0.2 | 0.9 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.2 | 0.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 1.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 2.8 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.2 | 0.3 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.2 | 0.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.2 | 0.3 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.2 | 1.4 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 0.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.2 | 0.9 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.7 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 1.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 0.5 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.8 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 0.5 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 1.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.6 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.5 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 0.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.5 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.3 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 0.6 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.2 | 1.4 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.2 | 0.2 | GO:0035483 | gastric emptying(GO:0035483) |
0.2 | 4.9 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.2 | 0.3 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.2 | 0.6 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.2 | 7.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.5 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 1.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 1.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.3 | GO:0021756 | striatum development(GO:0021756) |
0.1 | 0.3 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.1 | 0.9 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 1.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.7 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.1 | 0.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.4 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.3 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 1.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.4 | GO:1902570 | protein localization to nucleolus(GO:1902570) regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.1 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.1 | 0.4 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 0.3 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.1 | 0.4 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.3 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.7 | GO:0002858 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
0.1 | 0.4 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.9 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.4 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 2.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.3 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.1 | 0.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.7 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 10.5 | GO:0007411 | axon guidance(GO:0007411) |
0.1 | 0.2 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.1 | 0.1 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.4 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.5 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.8 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.3 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.7 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 1.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.8 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.1 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 0.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 1.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.3 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.1 | 0.3 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.4 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.3 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.1 | 0.8 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 2.8 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.3 | GO:0009155 | dGTP catabolic process(GO:0006203) purine deoxyribonucleotide catabolic process(GO:0009155) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.1 | 0.7 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.5 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.1 | 1.7 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.2 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.7 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.9 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.3 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.7 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.4 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.1 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.1 | 0.6 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 0.3 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.4 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.1 | 0.4 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.1 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.1 | 0.5 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 0.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.3 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.4 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.1 | 0.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.2 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.1 | 0.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 1.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.4 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.3 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.2 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.2 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.1 | 0.4 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.1 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.7 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 0.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.1 | GO:0048294 | negative regulation of isotype switching(GO:0045829) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.1 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.1 | 0.6 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.2 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.1 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.2 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.1 | 0.1 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 0.1 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 0.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.1 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.1 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.1 | 0.3 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.1 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.1 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.2 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.1 | 0.1 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.2 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.9 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.1 | GO:0003099 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.0 | 0.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.0 | 0.1 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.0 | 0.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.0 | 0.2 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.0 | 0.0 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.2 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.1 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.0 | 0.0 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.0 | 0.1 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.0 | 0.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.7 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.3 | GO:2000300 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.0 | 0.0 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.0 | 0.0 | GO:0061196 | positive regulation of hair follicle maturation(GO:0048818) fungiform papilla development(GO:0061196) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.0 | 0.2 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.0 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.0 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.0 | 0.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.0 | 0.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.2 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.0 | 0.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.0 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.0 | 0.5 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.0 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.0 | 0.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.0 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.0 | 0.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.3 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.3 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.0 | GO:0010513 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.0 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.0 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.0 | 0.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.0 | 0.2 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
0.0 | 0.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.0 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.0 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.0 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.2 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.1 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.1 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.0 | 0.0 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.0 | 0.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.0 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.0 | 0.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.1 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.3 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.0 | 0.2 | GO:0097531 | mast cell migration(GO:0097531) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.1 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.0 | 0.2 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.0 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 1.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.2 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 0.0 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.0 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.0 | 0.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.0 | GO:0061010 | gall bladder development(GO:0061010) |
0.0 | 0.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.0 | GO:0061308 | cardiac neural crest cell development involved in heart development(GO:0061308) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.0 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.0 | 0.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.0 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.0 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.0 | 0.0 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 1.1 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 27.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.7 | 5.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.2 | 3.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.1 | 5.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.9 | 5.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.8 | 2.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.8 | 21.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.7 | 10.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.7 | 8.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 2.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.7 | 1.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.7 | 5.2 | GO:0071437 | invadopodium(GO:0071437) |
0.7 | 7.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.6 | 1.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.6 | 16.8 | GO:0032420 | stereocilium(GO:0032420) |
0.6 | 2.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 8.3 | GO:0043196 | varicosity(GO:0043196) |
0.6 | 23.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.6 | 1.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.6 | 1.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.6 | 1.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.5 | 0.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.5 | 5.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 1.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.5 | 1.6 | GO:0072534 | perineuronal net(GO:0072534) |
0.5 | 14.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.5 | 1.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 1.4 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.5 | 1.4 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 1.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 2.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.4 | 1.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 1.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.4 | 2.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.4 | 1.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.4 | 2.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.4 | 2.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.4 | 5.7 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.4 | 1.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 5.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 1.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 1.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 3.1 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.3 | 0.6 | GO:0044393 | microspike(GO:0044393) |
0.3 | 1.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.3 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 0.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 1.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 1.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 1.2 | GO:0097433 | dense body(GO:0097433) |
0.2 | 1.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 0.9 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 1.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 1.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 1.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 1.2 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 1.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 0.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 0.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.2 | 4.0 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 1.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 0.7 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 0.5 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.2 | 1.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 1.0 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 0.5 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 0.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 21.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 1.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.3 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 1.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.6 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 1.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.5 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.4 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 1.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 1.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.6 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.5 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 1.3 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 2.1 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 2.3 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.9 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 0.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.4 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.3 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 1.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 2.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 1.1 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 2.5 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.0 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 0.0 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.0 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.0 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.0 | 0.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.8 | 8.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.7 | 10.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
2.5 | 12.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.3 | 4.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.9 | 9.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.4 | 4.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.3 | 4.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.2 | 3.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.2 | 8.4 | GO:0003680 | AT DNA binding(GO:0003680) |
1.2 | 4.6 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
1.0 | 2.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.9 | 3.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.9 | 3.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.9 | 4.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.9 | 3.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.9 | 3.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.9 | 2.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.8 | 3.2 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.8 | 4.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.7 | 15.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.7 | 2.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.7 | 2.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.7 | 2.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.7 | 1.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.7 | 0.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 1.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.6 | 3.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.6 | 0.6 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.6 | 1.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.6 | 7.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.6 | 1.7 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.6 | 1.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.6 | 3.9 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.6 | 1.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.6 | 1.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 2.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.5 | 17.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.5 | 0.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.5 | 1.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 2.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.5 | 5.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 4.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 3.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.5 | 1.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.5 | 1.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 5.4 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.4 | 1.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 1.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 1.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.4 | 1.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 1.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 2.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.4 | 2.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 1.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.4 | 1.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 0.8 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.4 | 1.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 1.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 1.1 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.4 | 2.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.4 | 10.7 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 1.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 4.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.4 | 1.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.4 | 1.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 1.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 1.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 1.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 1.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 1.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 1.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.3 | 1.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 2.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 0.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 1.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 1.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 0.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 1.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 3.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 0.8 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.3 | 4.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 1.8 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 1.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 3.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.3 | 1.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.2 | 1.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 0.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 2.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 1.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 2.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 4.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.5 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 1.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 0.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 3.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 3.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.6 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 3.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 0.8 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 1.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 2.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 1.0 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 1.0 | GO:0043830 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.2 | 1.0 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 2.1 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.2 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 0.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 1.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 1.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 2.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 2.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.2 | 2.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 0.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 2.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 1.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 3.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 1.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 1.4 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.2 | 0.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.7 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.7 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.4 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 2.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 2.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 1.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.6 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.6 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.3 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 1.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 1.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 2.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 1.2 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 5.2 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 1.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 1.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 2.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.3 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.2 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 2.8 | GO:0080131 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.1 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 0.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.3 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 2.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 1.1 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.6 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.5 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 1.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 2.0 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.2 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 1.3 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 4.0 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.0 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.0 | 0.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.1 | GO:0048045 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.0 | 0.1 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.0 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.1 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.0 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 0.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.6 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.0 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.0 | 0.0 | GO:0070061 | fructose binding(GO:0070061) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 1.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.6 | 1.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 1.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 1.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 0.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 0.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 10.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 7.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 1.5 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 3.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 0.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 4.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 3.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 2.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 2.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 1.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 1.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 1.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 10.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.6 | 8.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.6 | 13.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 1.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.6 | 8.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.5 | 20.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 5.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 3.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.4 | 3.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 4.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 1.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 13.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 3.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.3 | 0.9 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 0.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 4.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 2.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 4.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 6.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 3.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 3.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 3.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 2.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 4.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 3.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 2.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 1.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 2.7 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.2 | 1.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 3.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 2.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 0.3 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.1 | 1.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 4.1 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 1.8 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.6 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 2.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 2.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 2.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 0.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 2.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.4 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 3.1 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 1.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 3.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 0.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.1 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 1.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |